NewAmsterdam Pharma Co N.V.
NAMSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How NewAmsterdam Pharma Co N.V. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among NewAmsterdam Pharma Co N.V.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-09 · Kastelein Johannes Jacob Pieter: Larger than 79 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2026-03-05 · Kastelein Johannes Jacob Pieter: Larger than 80 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2026-03-02 · Davidson Michael H.: Larger than all 84 other insider sales of Ordinary Shares on file. SEC filing
- 2026-02-26 · Davidson Michael H.: Larger than 83 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2025-05-15 · Kling Douglas F: Larger than 77 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2025-04-15 · Kling Douglas F: Larger than 76 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2025-03-17 · Kling Douglas F: Larger than 77 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2025-03-04 · Kooij Louise Frederika: Larger than 82 of the 84 other insider sales of Ordinary Shares on file. SEC filing
- 2024-12-12 · Forbion Capital Fund IV Cooperatief U.A.: Larger than 81 of the 84 other insider sales of Ordinary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-22 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | S — Open market or private sale | −39,700 | 30.20 | SEC filing |
| 2026-06-22 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | S — Open market or private sale | −300 | 30.73 | SEC filing |
| 2026-05-26 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | S — Open market or private sale | −65,000 | 35.69 | SEC filing |
| 2026-03-11 | LANGE LOUIS G · Director | Ordinary Shares | S — Open market or private sale | −446 | 31.23 | SEC filing |
| 2026-03-11 | LANGE LOUIS G · Director | Ordinary Shares | S — Open market or private sale | −44,173 | 30.41 | SEC filing |
| 2026-03-09 | Kastelein Johannes Jacob Pieter · Chief Scientific Officer | Ordinary Shares | S — Open market or private sale | −101,409 | 30.29 | SEC filing |
| 2026-03-06 | Kastelein Johannes Jacob Pieter · Chief Scientific Officer | Ordinary Shares | S — Open market or private sale | −94,124 | 30.32 | SEC filing |
| 2026-03-06 | LANGE LOUIS G · Director | Ordinary Shares | S — Open market or private sale | −28,186 | 29.41 | SEC filing |
Showing 8 of 19 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-22 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | M — Exercise or conversion of derivative security | +25,000 | SEC filing |
| 2026-06-22 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | M — Exercise or conversion of derivative security | +15,000 | SEC filing |
| 2026-06-22 | Kooij Louise Frederika · Chief Accounting Officer | Option (right to buy) | M — Exercise or conversion of derivative security | −15,000 | SEC filing |
| 2026-06-22 | Kooij Louise Frederika · Chief Accounting Officer | Option (right to buy) | M — Exercise or conversion of derivative security | −25,000 | SEC filing |
| 2026-05-26 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | M — Exercise or conversion of derivative security | +5,000 | SEC filing |
| 2026-05-26 | Kooij Louise Frederika · Chief Accounting Officer | Ordinary Shares | M — Exercise or conversion of derivative security | +60,000 | SEC filing |
| 2026-05-26 | Kooij Louise Frederika · Chief Accounting Officer | Option (right to buy) | M — Exercise or conversion of derivative security | −60,000 | SEC filing |
| 2026-05-26 | Kooij Louise Frederika · Chief Accounting Officer | Option (right to buy) | M — Exercise or conversion of derivative security | −5,000 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.